Transition of Care Document

Patient	Taya Faber	Preferred Language	Unspecified
Date of birth	January 19, 1979	Sex	Female
Race	Unspecified	Ethnicity	Unspecified
Contact info	Primary Home: 4623 Maubert Ave Los Angeles, CA 90027, US Tel (Mobile): +1(206)-422-5594 Mail: tayafaber@gmail.com	Patient IDs	523809 2.16.840.1.113883.3.3710.999.44.88800115636.7770000101 2327 2.16.840.1.113883.3.3710.3 Ellkay 2.16.840.1.113883.3.3710.200.501 2327 2.16.840.1.113883.3.3710.200.500

Document Id	test-id-753598253 2.16.840.1.113883.3.3710.0
Document Created:	April 6, 2024, 16:21:20 +0000

Author	Diana Tagaban, Jaime S. Schwartz, MD
Contact info	Work Place: 240 S La Cienega Blvd Ste 200 Beverly Hills, CA 902113324, US Tel (Work Place): 3108825454

Encounter Id
Encounter Date	From , to ,
Encounter Participant
Contact info

Legal authenticator	Diana Tagaban signed at April 6, 2024, 16:21:20 +0000
Contact info	Work Place: 240 S La Cienega Blvd Ste 200 Beverly Hills, CA 902113324, US Tel (Work Place): 3108825454

Document maintained by	Jaime S. Schwartz, MD
Contact info	Work Place: 240 S La Cienega Blvd Ste 200 Beverly Hills, CA 902113324, US Tel (Work Place): 3108825454

Table of Contents

Social History

Code	Activity	Start Date	End Date
266927001 (SNOMED)	Unknown if ever smoked
Birth Sex	female
Sexual orientation	Unspecified
Gender identity	Unspecified

Problems

Problem	Code	Type	Status	Date of Diagnosis	Date of Resolution
No known problem	N/A	N/A	N/A	N/A

Allergies

Substance	RxNorm	Reaction(s)	Severity	Status	Start Date
No Allergy Information	N/A	N/A	N/A	N/A	N/A

Medications

Medication	Generic Name	RxNorm	Strength	Strength Unit	Route	Dose	Dose Form	Frequency	Date Started	Date Ended	Status	Indication	Sig
Acetaminophen Extra Strength	acetaminophen		500	mg	Oral	600mg	tablet	Q6-8H	02/17/2023		active	for pain	2 Tab PO Q 6-8H for pain
clindamycin HCl	clindamycin HCl	284215	300	mg	Oral	300mg	capsule	Q 12H	02/17/2023		active		1 Cap PO Q 12H
Colace	docusate sodium	1247756	100	mg	Oral	100mg	capsule	Q 8H	02/17/2023		active		2 Cap PO Q 8H until bowel movement
gabapentin	gabapentin	310431	300	mg	Oral	500mg	capsule	Q6-8H	02/17/2023		active	pain	1 Cap Q 6-8H for pain
ibuprofen	ibuprofen	197806	600	mg	Oral	600mg	tablet	Q6-8H	02/17/2023		active	for pain	1PO Q6-8H for pain
ondansetron	ondansetron	312087	8	mg	Oral	8mg	tablet,disintegrating	Q 8HR PRN	02/17/2023		active	nausea	1 Tab sublingual Q 8H PRN nausea
Percocet	oxycodone-acetaminophen	1049640	5-325	mg	Oral	5-325mg	tablet	Q4-6H PRN	02/17/2023		active	pain	1 Tab PO Q 4-6 H PRN for pain

Instructions

No Data

Results

No data

History of Procedures

Code	Site	Date Diagnosed	Status
Reduction mammoplasty (procedure)

Vital Signs

No data

Plan of Treatment

Code	Detail	Instructions
1114202	Xarelto 10 mg tablet	1 Tab PO daily for DVT prophylaxis
1049640	Percocet 5 mg-325 mg tablet	1 Tab PO Q 4-6 H PRN for pain
312087	ondansetron 8 mg disintegrating tablet	1 Tab sublingual Q 8H PRN nausea
197806	ibuprofen 600 mg tablet	1PO Q6-8H for pain
310431	gabapentin 300 mg capsule	1 Cap Q 6-8H for pain
1247756	Colace 100 mg capsule	2 Cap PO Q 8H until bowel movement
284215	clindamycin HCl 300 mg capsule	1 Cap PO Q 12H
165458	Acetaminophen Extra Strength 500 mg tablet	2 Tab PO Q 6-8H for pain

General Status

No data

Assessments

Immunizations

No data

Functional Status

No data

Mental Status

No data

Reason for Referral

No data

Review Of Systems

No Data

Goals

No data

Medical Equipment

No data

Health Concerns

No data

History of Present Illness

No Data

Family History

No data

Consultation Notes

No data

Laboratory Narrative

No data

Pathology Narrative

No data

Imaging Narrative

No data

Procedure Notes

No data

Progress Notes

No data

History And Physical Notes

No data